“ionis-pharmaceuticals” Archives

in
Entry Author Date Location
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Akcea Therapeutics Is Returning to Parent Ionis Pharma in $500M Buyout 08/31/20 Boston
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
With Harvard Tech and $5M, PIC Therapeutics Takes Aim at Cancer 04/15/20 Boston
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More 01/10/20 National
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s 12/17/19 Boston
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Bio Roundup: Biogen’s Reversal, FDA Moves Fast, a CF Cocktail & More 10/25/19 National
Akcea, Fresh Off C-Suite Shakeup, Dishes Heart Drug to Pfizer for $250M 10/07/19 Boston
Akcea Shakes Up Management and Shows Three Executives the Door 09/23/19 Boston
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More 05/17/19 San Diego
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Avidity Biosciences Gets $35M in Immunology R&D Deal with Eli Lilly 04/24/19 San Diego
Sanford Burnham Prebys, WARF Partner on Drug Discovery 03/25/19 San Diego
Bio Roundup: ASH Wrap, CRISPR Baby Fallout, Moderna’s Record IPO 12/07/18 National
With $90M Round, Stoke Eyes a “Spinraza For Epilepsy” And a 2019 IPO 10/23/18 Boston
Bio Roundup: Prices on TV, Novartis Hearts Radio, Warp Drive’s End 10/19/18 National
Spinraza Inventors Take Home $3M Breakthrough Prize in Life Sciences 10/17/18 National
FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam 10/05/18 Boston
Akcea to Cut Staff 10% in Wake of FDA Rejection of Rare Disease Drug 09/06/18 Boston
FDA Gives Thumbs-Down to Rare Disease Drug from Ionis, Akcea 08/27/18 San Diego
EU Regulators Approve Akcea’s Inotersen. FDA Decisions Are Next. 07/11/18 Boston
Biogen Makes Another Small Bet With Option Deal for TMS Stroke Drug 06/07/18 Boston
Bio Roundup: Moderna’s Billions, Cytokine Bets, Shire Acquired & More 05/11/18 National
Bio Roundup: CRISPR Tests, Parkinson’s Questions, Opioid Bills & More 04/27/18 National
SMA Day: AveXis Gene Therapy Creeps Forward as Biogen Drug’s Sales Slow 04/25/18 Boston
Biogen Pays $1B to Broaden Ionis Pact, Betting More on RNA Drugs 04/20/18 Boston
Page 1 of 2 next page »